Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033264242> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3033264242 endingPage "328" @default.
- W3033264242 startingPage "323" @default.
- W3033264242 abstract "Atrial fibrillation (AF) and atherosclerotic disease are independent risk factors for acute ischaemic stroke (AIS). The optimal biological marker which could allow differentiation between AF and non-AF AIS patients is still not available. Aim of the study. Aim of the present study was to investigate the role of pentosidine as a potential biological marker for AF in an AIS patient group. Materials and methods. Sixty-three acute ischaemic hemispheric stroke patients were recruited and divided into two groups according to the presumed underlying mechanism: with or without atrial rhythm disorders. Ten healthy volunteers were a reference group for serum level of pentosidine. Carotid artery ultrasound was performed, and common carotid artery stiffness and intima-media thickness were measured. Serum levels of pentosidine and selected routine biochemical risk factors for atherosclerosis (cholesterol and its lipoprotein fractions, homocysteine) were examined. Results. A higher serum level of pentosidine was observed in patients without atrial fibrillation (1,509 ± 485.13pmol/ml); a statistically significant difference was observed compared to the reference group (1,041.52 ± 411.17pmol/ml; p = 0.01), but not the AF patients (1,438.19 ± 495.97pmol/ml; p = 0.59). No significant difference in the non-AF group compared to the AF group for carotid intima-media thickness (IMT)/stiffness and pentosidine serum level was recorded. Conclusions and clinical implications. A higher serum level of pentosidine was observed in AIS patients without atrial fibrillation compared to the healthy volunteers. According to the results of the present study, no difference between these patients in the selected risk factors of atherosclerosis were observed. Further studies are needed to identify a reliable marker of AF that would bring added value to the standard diagnostic workup after acute ischaemic stroke." @default.
- W3033264242 created "2020-06-12" @default.
- W3033264242 creator A5025336398 @default.
- W3033264242 creator A5040441295 @default.
- W3033264242 creator A5047584370 @default.
- W3033264242 creator A5068244256 @default.
- W3033264242 date "2020-08-31" @default.
- W3033264242 modified "2023-09-24" @default.
- W3033264242 title "Pentosidine, advanced glycation end product, in acute ischaemic stroke patients with and without atrial rhythm disturbances" @default.
- W3033264242 doi "https://doi.org/10.5603/pjnns.a2020.0042" @default.
- W3033264242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32510570" @default.
- W3033264242 hasPublicationYear "2020" @default.
- W3033264242 type Work @default.
- W3033264242 sameAs 3033264242 @default.
- W3033264242 citedByCount "5" @default.
- W3033264242 countsByYear W30332642422021 @default.
- W3033264242 countsByYear W30332642422022 @default.
- W3033264242 countsByYear W30332642422023 @default.
- W3033264242 crossrefType "journal-article" @default.
- W3033264242 hasAuthorship W3033264242A5025336398 @default.
- W3033264242 hasAuthorship W3033264242A5040441295 @default.
- W3033264242 hasAuthorship W3033264242A5047584370 @default.
- W3033264242 hasAuthorship W3033264242A5068244256 @default.
- W3033264242 hasBestOaLocation W30332642421 @default.
- W3033264242 hasConcept C126322002 @default.
- W3033264242 hasConcept C127413603 @default.
- W3033264242 hasConcept C147990577 @default.
- W3033264242 hasConcept C164705383 @default.
- W3033264242 hasConcept C170493617 @default.
- W3033264242 hasConcept C2777090595 @default.
- W3033264242 hasConcept C2779161974 @default.
- W3033264242 hasConcept C2780645631 @default.
- W3033264242 hasConcept C2780758796 @default.
- W3033264242 hasConcept C3018755981 @default.
- W3033264242 hasConcept C71924100 @default.
- W3033264242 hasConcept C78519656 @default.
- W3033264242 hasConceptScore W3033264242C126322002 @default.
- W3033264242 hasConceptScore W3033264242C127413603 @default.
- W3033264242 hasConceptScore W3033264242C147990577 @default.
- W3033264242 hasConceptScore W3033264242C164705383 @default.
- W3033264242 hasConceptScore W3033264242C170493617 @default.
- W3033264242 hasConceptScore W3033264242C2777090595 @default.
- W3033264242 hasConceptScore W3033264242C2779161974 @default.
- W3033264242 hasConceptScore W3033264242C2780645631 @default.
- W3033264242 hasConceptScore W3033264242C2780758796 @default.
- W3033264242 hasConceptScore W3033264242C3018755981 @default.
- W3033264242 hasConceptScore W3033264242C71924100 @default.
- W3033264242 hasConceptScore W3033264242C78519656 @default.
- W3033264242 hasIssue "4" @default.
- W3033264242 hasLocation W30332642421 @default.
- W3033264242 hasLocation W30332642422 @default.
- W3033264242 hasOpenAccess W3033264242 @default.
- W3033264242 hasPrimaryLocation W30332642421 @default.
- W3033264242 hasRelatedWork W1534212684 @default.
- W3033264242 hasRelatedWork W2037893924 @default.
- W3033264242 hasRelatedWork W2040595346 @default.
- W3033264242 hasRelatedWork W2050552338 @default.
- W3033264242 hasRelatedWork W2375769711 @default.
- W3033264242 hasRelatedWork W2836980197 @default.
- W3033264242 hasRelatedWork W2918939009 @default.
- W3033264242 hasRelatedWork W3169227460 @default.
- W3033264242 hasRelatedWork W3198715625 @default.
- W3033264242 hasRelatedWork W4205963075 @default.
- W3033264242 hasVolume "54" @default.
- W3033264242 isParatext "false" @default.
- W3033264242 isRetracted "false" @default.
- W3033264242 magId "3033264242" @default.
- W3033264242 workType "article" @default.